Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy

This study has been completed.
Sponsor:
Information provided by:
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT00177112
First received: September 13, 2005
Last updated: January 31, 2008
Last verified: January 2008
  Purpose

The purpose of this study is to verify that the incidence rate of urinary tract infections after a routine outpatient cystoscopy is the same for non-sterile (clean) and sterile procedural techniques.


Condition Intervention Phase
Urinary Tract Infections
Procedure: clean patient preparation for cystoscopy
Procedure: sterile patient preparation for cystoscopy
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy

Resource links provided by NLM:


Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Primary Outcome Measures:
  • To verify that the incidence rate of urinary tract infections after a routine outpatient cystoscopy is the same for non-sterile (clean) and sterile procedural techniques

Estimated Enrollment: 275
Study Start Date: June 2005
Study Completion Date: October 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Patients undergoing routine outpatient flexible cystoscopy

Exclusion Criteria:

  • Patients who have had a urinary tract infection within 3 months prior to flexible cystoscopy
  • Patients with an indwelling catheter
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00177112

Locations
United States, Minnesota
VAMC Minneapolis
Minneapolis, Minnesota, United States, 55417
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Investigators
Principal Investigator: Kyle Anderson, MD VAMC Minneapolis
  More Information

No publications provided

Responsible Party: Manoj Monga, MD, University of Minnesota
ClinicalTrials.gov Identifier: NCT00177112     History of Changes
Other Study ID Numbers: 0412M65852, 3519A
Study First Received: September 13, 2005
Last Updated: January 31, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
Cystoscopy

Additional relevant MeSH terms:
Urinary Tract Infections
Infection
Urologic Diseases
Disinfectants
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 16, 2014